Search

Author/Creator Haenel, Mathias

1. Cyclophosphamide‐based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsE. (24th May 2017)

Authors:
Baertsch, Marc‐Andrea; Schlenzka, Jana; Lisenko, Katharina; Krzykalla, Julia; Becker, Natalia; Weisel, Katja; Noppeney, Richard; Martin, Hans; Lindemann, Hans W.; Haenel, Mathias; Nogai, Axel; Scheid, Christof; Salwender, Hans; Fenk, Roland; Graeven, Ullrich; Reimer, Peter; Schmidt‐Hieber, Martin...
Journal:
European journal of haematology
Issue:
Volume 99:Number 1(2017)
Page Start:
42
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells. Issue 1 (December 2015)

Authors:
Meißner, Tobias; Seckinger, Anja; Hemminki, Kari; Bertsch, Uta; Foersti, Asta; Haenel, Mathias; Duering, Jan; Salwender, Hans; Goldschmidt, Hartmut; Morgan, Gareth; Hose, Dirk; Weinhold, Niels
Journal:
BMC medical genomics
Issue:
Volume 8:Issue 1(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial. Issue 4 (April 2021)

Authors:
Frontzek, Fabian; Ziepert, Marita; Nickelsen, Maike; Altmann, Bettina; Glass, Bertram; Haenel, Mathias; Truemper, Lorenz; Held, Gerhard; Bentz, Martin; Borchmann, Peter; Dreyling, Martin; Viardot, Andreas; Kroschinsky, Frank P; Metzner, Bernd; Staiger, Annette M; Horn, Heike; Ott, German; Rosenwa...
Journal:
Lancet
Issue:
Volume 8:Issue 4(2021)
Page Start:
e267
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Doubling rituximab in high‐risk patients with aggressive B‐cell lymphoma ‐results of the DENSE‐R‐MegaCHOEP trial. (5th December 2018)

Authors:
Friedrichs, Birte; Nickelsen, Maike; Ziepert, Marita; Altmann, Bettina; Haenel, Mathias; Viardot, Andreas; Schmidt, Christian; Ruebe, Christian; Loeffler, Markus; Pfreundschuh, Michael; Rosenwald, Andreas; Glass, Bertram; Lenz, Georg; Schmitz, Norbert
Journal:
British journal of haematology
Issue:
Volume 184:Number 5(2019)
Page Start:
760
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial. Issue 10216 (21st December 2019)

Authors:
Poeschel, Viola; Held, Gerhard; Ziepert, Marita; Witzens-Harig, Mathias; Holte, Harald; Thurner, Lorenz; Borchmann, Peter; Viardot, Andreas; Soekler, Martin; Keller, Ulrich; Schmidt, Christian; Truemper, Lorenz; Mahlberg, Rolf; Marks, Reinhard; Hoeffkes, Heinz-Gert; Metzner, Bernd; Dierlamm, Judi...
Journal:
Lancet
Issue:
Volume 394:Issue 10216(2019)
Page Start:
2271
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma. Issue 1 (December 2016)

Authors:
Baertsch, Marc-Andrea; Schlenzka, Jana; Mai, Elias; Merz, Maximilian; Hillengaß, Jens; Raab, Marc; Hose, Dirk; Wuchter, Patrick; Ho, Anthony; Jauch, Anna; Hielscher, Thomas; Kunz, Christina; Luntz, Steffen; Klein, Stefan; Schmidt-Wolf, Ingo; Goerner, Martin; Schmidt-Hieber, Martin; Reimer, Peter;...
Journal:
BMC cancer
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗